Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

1.1K
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.1K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

5.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.3K
Conduction System of the Heart01:19

Conduction System of the Heart

13.1K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
13.1K
Conduction System of the Heart01:20

Conduction System of the Heart

6.0K
The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
6.0K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

2.7K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

595
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
595

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Method development and production of an ambient-stable blood certified reference material for total mercury, methylmercury, and trace elements.

Analytica chimica acta·2026
Same author

Flexible Mesh-Structured Single-Walled Carbon Nanotube Thermoelectric Generators with Enhanced Heat Dissipation for Wearable Applications.

Micromachines·2026
Same author

Tofogliflozin attenuates liver steatosis and fibrosis in non-diabetic non-alcoholic steatohepatitis mice.

BMC gastroenterology·2026
Same author

Impact of Air Temperature and Humidity on Performance of Heat-Source-Free Water-Floating Single-Walled Carbon Nanotube Thermoelectric Generators for IoT Sensors.

Sensors (Basel, Switzerland)·2025
Same author

The clinical impact of genetic testing in comprehensive cardiomyopathies.

Journal of cardiology·2025
Same author

SWCNT/PEDOT:PSS/SA Composite Yarns with High Mechanical Strength and Flexibility via Wet Spinning for Thermoelectric Applications.

Sensors (Basel, Switzerland)·2025

Related Experiment Video

Updated: Apr 28, 2026

Programmed Electrical Stimulation in Mice
07:29

Programmed Electrical Stimulation in Mice

Published on: May 26, 2010

20.3K

Device-Specific Responses to Pacemaker-Mediated Arrhythmia in Patients With Prolonged Ventriculoatrial Conduction: A

Mitsuru Tsunomori1, Teruhiko Imamura2, Daisuke Nagamine1

  • 1Medical Equipment Management Center Toyama University Hospital Toyama Japan.

Journal of Arrhythmia
|April 27, 2026
PubMed
Summary

Pacemaker-mediated tachycardia (PMT) detection and termination vary by device, especially with prolonged ventriculoatrial conduction (VAC). Pacemakers with longer refractory periods and specific algorithms offer better protection against these arrhythmias.

Keywords:
endless loop tachycardiapacemaker‐mediated tachycardiarepetitive nonreentrant ventriculoatrial synchronyventriculoatrial conduction

More Related Videos

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.5K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

16.6K

Related Experiment Videos

Last Updated: Apr 28, 2026

Programmed Electrical Stimulation in Mice
07:29

Programmed Electrical Stimulation in Mice

Published on: May 26, 2010

20.3K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.5K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

16.6K

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Device Technology

Background:

  • Pacemaker-mediated tachycardia (PMT) can be difficult to detect and terminate, particularly with prolonged ventriculoatrial conduction (VAC).
  • The effectiveness of anti-PMT algorithms and the utility of DDI mode in these scenarios require further investigation.

Purpose of the Study:

  • To evaluate the performance of different dual-chamber pacemakers in detecting and terminating PMT during prolonged VAC.
  • To assess the behavior of pacemakers in DDI mode, focusing on atrial sensing within the post-ventricular atrial refractory period (PVARP) and atrial pacing adjustments.

Main Methods:

  • Five dual-chamber pacemakers (Abbott, BIOTRONIK, Boston Scientific, Medtronic, MicroPort CRM) were tested using an electrophysiological simulator.
  • Simulations were conducted with VAC times of 450 ms and 550 ms, assessing PMT detection/termination in DDD mode and atrial sensing/pacing in DDI mode.

Main Results:

  • PMT detection varied, with most devices detecting it at 450 ms VAC, but only Abbott terminating it at 550 ms VAC. Atrial sensing within PVARP occurred in most devices at 450 ms VAC, and only BIOTRONIK at 550 ms VAC.
  • BIOTRONIK, Boston Scientific, and Medtronic adjusted atrial pacing after sensing within PVARP, unlike Abbott, which led to repetitive ventriculoatrial synchrony.

Conclusions:

  • Pacemaker anti-PMT performance differs significantly across manufacturers.
  • Devices with longer PVARP and atrial pacing delay algorithms provide better protection against PMT during prolonged VAC.
  • Individualized pacemaker selection and programming are crucial for managing pacemaker-mediated arrhythmias.